SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Medical - Drugs > Nektar Therapeutics (NKTR)

Bad link... try this one for AMLN [#msg-10433899]

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SeriousMoney Member Profile
 
Followed By 30
Posts 7,965
Boards Moderated 5
Alias Born 04/05/05
160x600 placeholder
Nektar Therapeutics Initiates Clinical Study of NKTR-358, a First-in-Class Regulatory T Cell Stimulator, Being Developed for ... "PR Newswire (US)" - 3/27/2017 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/22/2017 6:05:07 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/20/2017 7:38:16 AM
NKTR-181 Meets Primary and Secondary Endpoints in Phase 3 SUMMIT-07 Study in Chronic Pain "PR Newswire (US)" - 3/20/2017 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/17/2017 6:04:09 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/16/2017 6:04:29 PM
Nektar to Webcast Presentation at Cowen and Company's 37th Annual Health Care Conference in Boston "PR Newswire (US)" - 3/2/2017 7:01:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/1/2017 4:37:25 PM
Nektar Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting "PR Newswire (US)" - 3/1/2017 4:30:00 PM
Nektar Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results "PR Newswire (US)" - 3/1/2017 4:10:00 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/1/2017 3:06:12 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/23/2017 6:33:47 PM
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2016 on Wednesday, March 1, 2017, After Close of U... "PR Newswire (US)" - 2/22/2017 5:07:00 PM
Clinical Data from Phase 1 Dose-Escalation Study of Single-Agent NKTR-214 in Patients with Renal Cell Carcinoma Presented at ... "PR Newswire (US)" - 2/18/2017 7:24:00 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/10/2017 11:02:54 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/9/2017 12:12:35 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/6/2017 5:21:51 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/31/2017 10:54:55 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/26/2017 9:41:31 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/17/2017 12:51:41 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/10/2017 4:31:26 PM
Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 35th Annual J.P. Morgan Healthcare Conference in S... "PR Newswire (US)" - 1/5/2017 9:00:00 AM
Shire Announces FDA Approval of Adynovate® [Antihemophilic Factor (Recombinant), Pegylated] for use in Children and Surgical... "PR Newswire (US)" - 12/27/2016 7:00:00 AM
Shire Announces FDA Approval of Adynovate® [Antihemophilic Factor (Recombinant), Pegylated] for use in Children and Surgical... "PR Newswire (US)" - 12/27/2016 7:00:00 AM
SeriousMoney   Friday, 03/31/06 07:48:21 PM
Re: bernoulli post# 31
Post # of 163 
Bad link... try this one for AMLN [#msg-10433899]




"Growth is all that matters!" CRAMER
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist